Title : The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report.

Pub. Date : 2019 Oct 31

PMID : 31672129






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CASE PRESENTATION: A 28-years-old woman in the 26th week of gestation diagnosed with FLT3/ITD-mutated AML, complete remission was induced by Daunorubicin and Cytarabine, and subsequently with 5-azacytidine (75 mg/m2 daily for 7 days) with no fetal hematological or toxicity issues. Daunorubicin fms related receptor tyrosine kinase 3 Homo sapiens